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Ah&act It was previously reported that monosialosylgangliopemaosyl ceramide (GalNAc-GMlb) was a major ganglioside in Xenopus Zaevis 
oocytes. Here we determined biosynthetic pathways for the gauglioside by detailed measurements of glycosyltrausferase activities. CMP- 
NeuAc:asialo-GM1 a2-3 sialyltransferase (a2-3 ST) and UDP-GalNAc: GMlb fi1-4 N-acetylgalactosaminyltransferase @l-4 GalNAcT) 
exhibited much higher activity than CMP-NeuAc:GalNAc-GA1 a2-3 ST and UDP-GalNAc:asialo-GM1 B1-4 GalNAcT, respectively. These 
observations indicated the existence of a unique biosynthetic pathway in the oocytes as follows; asialo-GM l--f GM 1 b + GalNAc-GM1 b. 
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1. Intmduetlon 
It is well known that gangliosides are one of the most ubiq- 
uitous components of the plasma membrane. In gangliosides, 
more than 100 molecular species have been identified on the 
basis of the diversity of their carbohydrate structures [l]. The 
structural diversity is caused by specific glycosyltransferases 
which sequentially transfer monosaccharides [2]. Previous stud- 
ies have suggested that gangliosides may play important rolds 
in a variety of biological phenomena, such as cell-cell and 
cell-substratum interactions, growth and differentiation, cell 
transformation, and signal transduction pathways (for reviews 
see [3-6]). 
Xenopus laevis oocytes are a suitable system for exploring 
molecules involved in development because of the large amount 
of information available on embryonic morphogenesis [7]. 
However, detailed studies have not been carried out concerning 
gangliosides in Xenopus laevis oocytes. Before this system is 
adopted for investigation of the effect of active gangliosides on 
development, it is essential to obtain fundamental information, 
such as the composition of gangliosides and the enzymatic 
property of glycosyltransferases in the oocytes. 
Previously we determined the acidic glycospbingolipid com- 
ponents and the complete structure of a major ganglioside in 
Xenopus laevis oocytes [8]. In this study, we characterized en- 
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Abbreviations: The nomenclature used for gaugliosides i  based on the 
system of Svennerholm [24] and the IUPAC-IUB [25]. Cer, ceramide; 
GalNAc, N-acetylgalactosamine; NeuAc, N-acetylneuraminic acid; 
CMP-NeuAc, cytidine-5’-phosphate-N-acetylneuramiuic ac d; lacto- 
sylceramide, LacCer; asialo-GM2, Gg3Cer; asialo-GM1 , Gg4Cer; 
GalNAoGA 1, IV’GalNAcGg4Cer; GalNAoGM 1 a, IV4Gal-NAcII’ 
NeuAcGg4Cer; GalNAc-GM1 b, IV“GalNAcIV’NeuAcGg4Cer; ST(s), 
sialyltrausferase(s); GalNAcT(s), N-acetylgalactosaminyltransfer- 
ase(s); GalT(s), galactosyltransferase(s); GM3 syuthase, CMP-NeuAc: 
lactosylceramide a2-3 sialyltransferase; GMlb synthase, CMP-NeuAc: 
a&lo-GM1 a2-3 sialyltrausferase; TDC, sodium taurodeoxycholate; 
SDS, sodium dedecylsulfate. 
dogenous glycosyltransferases responsible for the synthesis of 
gangliosides in the oocytes and found a unique biosynthetic 
pathway for gangliosides. 
2. Materials and methods 
2.1. Animals 
Xenopus Zaevis females were purchased from the Nippon Bio-Supp. 
Center (Tokyo, Japan). 
2.2. Materials 
CMP-[9-3H]NeuAc (862.1 GBq/mmol), UDP-[1-3H]Gal (477.3 GBq/ 
mmol), and UDP-[I-‘H]GalNAc (307.1 GBq/mmol) were purchased 
from Du Pont/NEN Research Products (Boston, USA). GM3 was 
purified from dog erythrocytes. GalNAc-GMlb was isolated from Xen- 
opus Zaevis oocytes [8]. GalNAc-GA1 was obtained by desialylation of 
GalNAoGMl b with sialidase (EC 3.2.1.18) from Arthrobacter ureafa- 
ciens (Nacalai Tesque Inc., Tokyo, Japan). GMlb was synthesized 
from asialo-GM1 by a2-3 ST using a rat liver Golgi fraction [9] accord- 
ing to the method of Hidari et al. [lo]. All other chemicals were of the 
highest purity available. 
2.3. Preparation of the enzyme fraction from Xenopus laevis oocytes 
Immature oocytes without any hormone treatment were dissociated 
from the ovaries. The oocytes (8.0 g, wet weight) were homogenized in 
3 mM Tris-HCl buffer (pH 7.4) containing 0.25 M sucrose and 0.1 mM 
EDTA, using a Potter-Elvehjem homogenizer. The homogenate was 
centrifuged for 10 min at 5,000 x gin a Hitachi RPR 20-2 rotor (Tokyo, 
Japan). The supemataut was further centrifuged for 1 h at 200,000 x g 
in a Beckman 60 Ti rotor (CA, USA). After the supemataut was 
removed, the pellet was suspended in 150 mM sodium cacodylate/ 
hydrochloric acid buffer (pH 6.5) containing 1mM 2-mercaptoethauol. 
This preparation was used as the enzyme source throughout he exper- 
iments. All steps were performed at 04°C. Protein concentrations of 
the enzyme fraction were determined with the Micro BCA Protein 
Assay Reagent (Pierce, IL, USA), using bovine serum albumin as a 
standard [ll]. 
2.4. Glycosyltransferase assays 
All the enzyme reactions were carried out in a total volume of 50 ml 
at 37°C for 2 h. (i) The assay of ST was performed by the procedure 
of Pohlentz et al. [12] with a slight modification. The reaction mixture 
comprised 0.3 mM acceptor-substrate, 3.2 mM CMP-[‘H]NeuAc 
(155 MBq/mmol), 0.3% (w/v) Triton CF-54, 10 mM MnCl,, 10mM 
MgCl,, 1 mM 2-mercaptoethauol, 150 mM sodium cacodylate/HCl 
buffer @H 6.5), and 280 pg of enzyme protein. (ii) The assay of GalT 
was performed following the procedure of Wilkinson et al. [ 131 with a 
slight modification. The mixture comprised 0.5 mM acceptor-substrate, 
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0.5 mM UDP-[‘H]Gal(l85 MBq/mmol), 0.5% (w/v) Triton X-100, 10 
mM MnCl,, 150 mM sodium cacodylate/HCl buffer @H 6.0), and 280 
pg of enzyme protein. (iii) The assay of GalNAcT was performed by 
the procedure of Senn et al. [14] with a slight modification. The mixture 
comprised 0.3 mM acceptor-substrate, 0.1 mM UDP-[‘HjGalNAc (155 
MBq/mmol), 0.5% (w/v) T&on X-100, 10 mM MnCl,, 5 mM CDP- 
choline, 64 mM sodium cacodylate/HCl buffer @H 7.0), and 280 pg of 
enzyme protein. The activity of each glycosyltransferase increased lme- 
arly with increasing enzyme protein concentration a d with increasing 
incubation time under the experimental conditions (data not shown). 
2.5. Quantification and identification of reaction products 
The enzyme reaction was terminated with 450 ml of distilled water. 
The reaction product was separated by a C,, reverse-phase column 
(BOND ELUT, size 3 ml; Varian Sample Preparation Products, USA) 
according to the method of Kundu and Suzuki [15]. The enzyme activity 
was calculated from the incorporation of radiolabeled sugar into an 
acceptor-substrate by measurement with a liquid scintillation counter. 
For identification ofproducts, the products were spotted on an HPTLC 
or plastic TLC plate that was developed with chloroform/methanol/ 
0.5% CaCl, (55:45: 10, v/v/v), and then exposed to an X-ray film or 
immunostained using the procedure of Higashi et al. [16]. 
Table 1 
Activities of glycosultransferase in Xenopus Zaevis oocytes 
Glycosyltrans- Substrate Product Activity 
ferase @moYh, mg 
protein) 
a2-3ST Lactosylceramide GM3 30.2 + 4.0 
Asialo-GM1 GMlb 109.7 f 8.9 
GalNAc-GA1 GalNAc-GM 1 b 27.5 f 9.1 
p-4 GalNAcT Lactosylceramide Asialo-GM2 41.8 f 10.9 
Asialo-GM 1 GalNAc-GA1 N.D. 
GM3 GM2 58.5 k 11.8 
GMlb GalNAc-GM 1 b 78.6 f 4.6 
/31-3 GalT Asialo-GM2 Asialo-GM1 83.3 f 2.6 
GM2 GMla 106.2 k 2.7 
The values indicated are averages f 2 SD. for three independent 
experiments. 
N.D., not detected. 
3. Results predominantly existed in Xenopus laevis oocytes (Fig. 1). In- 
deed, these gangliosides are mainly found in the tissue [8]. 
3.1. Aqivity of endogenous glycosyltransferases in Xenopus 
oocytes 
Three kinds of glycosyltransferases, a2-3 ST, /31-4 GalNAcT 
and /31-3 GalT were investigated in the oocytes (Table 1). The 
activity of GMlb synthase was over 4-fold higher than that of 
CMP-NeuAc : GalNAc-GA1 a2-3 ST. GalNAc-GM 1 b syn- 
thase (UDP-GalNAc: GMlb@l-4 GalNAcT) was also detected 
with potent activity. However, GalNAc-GA1 synthase was not 
detected significantly. These findings showed that GalNAc- 
GMlb was formed from asialo-GM1 followed by GMlb syn- 
thesis (Fig. 1). Furthermore, several ganglioside formations 
were conspicuously found as follows; asialo-GM2 -_) asialo- 
GM 1, lactosylceramide + asialo-GM2, GM2 -+ GM 1 a, and 
GM3+GM2. These results also indicated that bio- 
synthetic pathways of a-series and asialo-series gangliosides 
3.2. Characterization of sialyltransferases in Xenopus oocytes 
The activity of glycosyltransferases including STs, GalTs and 
GalNAcTs was recovered in a fraction of 200,000 x g pellets. 
GM3 and GM 1 b synthases were here enzymatically character- 
ized because of their importance in the metabolic flow of the 
ganglioside biosynthesis. Both sialyltransferases had a similar 
optimal pH (6.5-6.7) for their activities: their properties are 
summarized in Table 2. In divalent cations, GM3 synthase 
activity was enhanced more than twice in the presence of M$ 
or Mn2+, and reduced by Cu2+ or Zn’+. In particular, Zn2+ 
completely inhibited the activity. On the other hand, GMlb 
synthase activity was reduced in the presence of Fe’+. The 
divalent cations examined were not essential for the activity of 
GMlb synthase. Among the detergents tested, Triton CF-54 
asialo-series 
GalN A@ I -4GalP I -4GlcP I - ICer 
asialo-GM2 
asialo-GM I Gal~l-3GalNAc~l-4Gal~l-4GlcPI_ICet 
7 ’ 
JeuAca2-3Gal~I-3GalNAc~I-4Gal~I-4Glc~I-lCer 
(1 
-_) NeuAccr2-3Galp I-4GlcbI - ICer 
(3) 
GM3 
GalNAcP I -4GalP I -4Glcp I - ICer 
_ s 
NeuAcai (4) 
GM2 
J 
NeuAcai 
GMla 
a-series 
~alNAc~I-4Gal~I-3GalNAcj3l-4Gal~l-4Glc~l-ICer 
GalNAc-GA I 
GalNAc~l-4G~~l-3GalNAc~l-4Gal~l-4Glc~l-lCer 
NettAck 
GalNAc-GM 1 b 
Fig. 1. The biosynthetic pathway for gangliosides in Xenopus Zaevis oocytes. (1) ~2-3 ST; (2) cc2-3 ST; (3) bl-4 GaINAcT; (4) PI-3 GaK (5) B1-4 
GalNAcT. Bold arrows indicate high activities of glycosyltransferases. 
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Fig. 2. Identification of reaction products by autoradiography. Lane S, standard glycospbingolipids tained with orcinol reagent; lane P, reaction 
product with glycosyltransferasc in Xenopus laevis oocytes on autoradiography. Panel 1, product from asialo-GM1 (0.3 mM) by ST. Panel 2, product 
from GMlb (0.3 mM) by GalNAcT. 
effectively activated both synthases. The optimal concentration 
of Triton CF-54 was commonly 0.2-0.4% (w/v) (data not 
shown). Without detergents the enzyme activities were not de- 
tected, indicating that both STs in the oocytes are membrane- 
bound enzymes similar to other glycosyltransferases from var- 
ious tissues previously reported (for a review see [17]). Under 
the optimal assay conditions for GMlb syuthase defined above, 
the apparent K,,, values for asialo-GM 1 and CMP-NeuAc were 
63.6 and 159.5 mM, respectively. The K,,, value for CMP- 
NeuAc of Xenopus GMlb synthase was over lo-fold higher 
Table 2 
Enzymatic properties of sialyltransferases from XenopuF oocytes 
Effecters Relative activities(%) 
GM3 svnthase GMlb svnthase 
Divalent cations” 
Without cation 
Mg2+ 
Mn2+ 
Ca” 
cu*+ 
Fe*’ 
Zn2+ 
Detergents” 
Triton CF-54 
Triton X-100 
Tween80 
TDC 
SDS 
100 
213 
234 
120 
32 
102 
0 
100 
115 
13 
0 
0 
100 
94 
96 
98 
18 
64 
23 
100 
38 
0 
0 
0 
“The sialyltransferase assay conditions are described in section 2 with- 
out each effector. The concentration of effecters were 10 mM for 
divalent cations and 0.4% for detergents. 
than that of .z2-3 sialyltransferases (GM3 synthase or GMlb 
synthase) from the rat liver, whereas the affinity with glycol- 
ipid-acceptor was to the same extent [12,18]. 
3.3. Ia’entl@cation of reaction products 
The reaction products by glycosyltransferases involved in 
GalNAc-GM1 b biosynthesis were determined by autoradi- 
ography (Fig. 2). In panel 1, a product from asialo-GM1 by ST 
co-migrated with standard GM 1 b on a HPTLC plate. In panel 
2, a product from GMlb by GalNAcT exhibited identical TLC 
mobility to standard GalNAc-GMlb isolated from Xenopus 
oocytes. These results indicated that the products were GMlb 
and GalNAc-GM1 b, respectively. Furthermore, the product by 
ST was confirmed to be GMlb by the TLC-immunostaining 
method with a mouse monoclonal antibody, M2590, that re- 
acted with the terminal non-reducing sugar sequence, 
NeuAcaZ3Gavl-R [19] (Fig. 3). 
4. Discussion 
GalNAc-GMlb was previously determined as a major gan- 
glioside in the oocytes [8]. In this study, we found two different 
biosynthetic pathways for gangliosides in Xenopus oocytes 
(Fig. 1). One was a unique pathway through which GalNAc- 
GMlb was formed as a major ganglioside. The other was a 
ubiquitous pathway in the mammalian neural system, in which 
GMla was predominantly formed [20]. 
Previous studies demonstrated the existence of several kinds 
of GalNAcTs from different species and tissues [12,21-231. Our 
study shows high activity of both GM2 and GalNAc-GMlb 
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Fig. 3. Identification of a reaction product by TLC-immunostaining 
with the M2590 antibody. Lane 1, products without any substrates by 
ST in Xenopus laevb oocytes. Lane 2, products from asialo-GM1 
(0.3 mM) by ST in Xenopus laevis oocytes. 
synthase. Since crude homogenates from the oocytes were used 
as the enzymatic source, it is impossible to distinguish whether 
two synthetic steps are catalyzed by a single GalNacT or not. 
Further study is required to elucidate this question. 
We have obtained information on the enzymatic properties 
of glycosyltransferases and the biosynthesis of gangliosides in 
Xenopus luevis oocytes for the first time. These observations 
will serve for studying the biological functions of gangliosides 
on development and differentiation. 
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